Vimarsana
Biggest News Aggregation in the World

Page 6 - Peter Schmid News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Peter Schmid. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Peter Schmid Today - Breaking & Trending Today

Inside St Bartholomew's, the world's oldest hospital - Vimarsana News

Inside St Bartholomew's, the world's oldest hospital

As the world-leading hospital approaches its 900th anniversary, its resilient and innovative approach can teach us a lot

HEALTH NOTES: Thousands more breast cancer sufferers to be given life-saving drug - Vimarsana News

HEALTH NOTES: Thousands more breast cancer sufferers to be given life-saving drug

The UK medicines watchdog the MHRA has now approved the treatment, called Enhertu, as a second line therapy.

Daiichi Sankyo and AstraZeneca's Enhertu delivers promising trial results - Vimarsana News

Daiichi Sankyo and AstraZeneca's Enhertu delivers promising trial results

Enhertu reduced the risk of disease progression or death compared to chemotherapy in certain patients with metastatic breast cancer - News - PharmaTimes

Adjuvant Everolimus Fails to Stop Recurrence in Early High-Risk Breast Cancer - Vimarsana News

Adjuvant Everolimus Fails to Stop Recurrence in Early High-Risk Breast Cancer

More than half of everolimus-treated patients permanently discontinued treatment

Neoadjuvant Pembrolizumab Plus Chemo Treats Early TNBC - Vimarsana News

Neoadjuvant Pembrolizumab Plus Chemo Treats Early TNBC

The event-free survival rate was higher with neoadjuvant pembrolizumab plus chemotherapy, compared with chemotherapy alone.